(ABUS) Arbutus Biopharma - Performance 1.9% in 12m
ABUS performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
2.23%
#34 in Peer-Group
Rel. Strength
39.77%
#4644 in Stock-Universe
Total Return 12m
1.92%
#62 in Peer-Group
Total Return 5y
70.59%
#18 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 4.56 USD |
| 52 Week Low | 2.88 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 15.37 |
| Buy/Sell Signal +-5 | -0.37 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ABUS (1.9%) vs XBI (-7.2%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.11% | 68.3% | 77.5% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.3% | -6.89% | 148% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.9% | -1.4% | 35.4% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
0.57% | 33% | -5.3% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.89% | -5.88% | 1.36% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.2% | 59.2% | -5.89% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
0.66% | 61.7% | -9.1% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
3.23% | 38.8% | 14.5% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: ABUS vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ABUS
| Total Return (including Dividends) | ABUS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -5.06% | 4.38% | 4.99% |
| 3 Months | -9.12% | 5.22% | 10.23% |
| 12 Months | 1.92% | -7.16% | 14.42% |
| 5 Years | 70.59% | -24.61% | 110.17% |
| Trend Score (consistency of price movement) | ABUS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -67.2% | 3.5% | 79.1% |
| 3 Months | 25.9% | 75.7% | 95.5% |
| 12 Months | -63.5% | -85.1% | 44.7% |
| 5 Years | -5.8% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th35.50 | -9.04% | -9.57% |
| 3 Month | %th34.00 | -13.63% | -17.55% |
| 12 Month | %th69.50 | 9.78% | -10.93% |
| 5 Years | %th92.00 | 126.28% | -18.84% |
FAQs
Does Arbutus Biopharma (ABUS) outperform the market?
Yes,
over the last 12 months ABUS made 1.92%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.16%.
Over the last 3 months ABUS made -9.12%, while XBI made 5.22%.
Performance Comparison ABUS vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ABUS vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -6.7% | -10.1% | -9.8% | -13% |
| US NASDAQ 100 | QQQ | -6.3% | -10.5% | -11.3% | -12% |
| German DAX 40 | DAX | -5.7% | -4.5% | -21.4% | -28% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -4% | -9.2% | -10.2% | -16% |
| Hongkong Hang Seng | HSI | -4.7% | -12.2% | -28.3% | -35% |
| India NIFTY 50 | INDA | -5.6% | -7% | -7.2% | 2% |
| Brasil Bovespa | EWZ | -9.4% | -13.1% | -32.7% | -12% |
ABUS vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -6.6% | -10.8% | -14.1% | -24% |
| Consumer Discretionary | XLY | -7.8% | -7.9% | -2.9% | -17% |
| Consumer Staples | XLP | -7% | -4.9% | -9.2% | -8% |
| Energy | XLE | -7.3% | -11.2% | -5% | 3% |
| Financial | XLF | -6.8% | -8.6% | -13% | -26% |
| Health Care | XLV | -5.6% | -7.5% | -2.3% | 7% |
| Industrial | XLI | -7.5% | -9.3% | -16.6% | -22% |
| Materials | XLB | -9.8% | -10.9% | -14% | -5% |
| Real Estate | XLRE | -5.8% | -5.9% | -8.4% | -11% |
| Technology | XLK | -6.2% | -14.1% | -12.8% | -10% |
| Utilities | XLU | -5.4% | -4.6% | -11% | -21% |
| Aerospace & Defense | XAR | -6.9% | -12.6% | -28.1% | -46% |
| Biotech | XBI | -6.3% | -9.4% | 4.3% | 9% |
| Homebuilder | XHB | -11.6% | -16.7% | -3.8% | -4% |
| Retail | XRT | -9.3% | -10.6% | -4.6% | -8% |
ABUS vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -7.6% | -13.7% | -1.30% | 9% |
| Natural Gas | UNG | -1.8% | 3.5% | 6.3% | 8% |
| Gold | GLD | -5.2% | -4.3% | -29.1% | -42% |
| Silver | SLV | -5.2% | -10.3% | -26.5% | -21% |
| Copper | CPER | -9% | -11.2% | -30.4% | -15% |
ABUS vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -4.9% | -8.3% | -5.2% | 1% |
| iShares High Yield Corp. Bond | HYG | -5.2% | -7% | -7.9% | -9% |